tetradecanoylphorbol acetate has been researched along with 1-palmitoyl-2-(6-(n-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Julien, M; Millot, C; Tocanne, JF; Tournier, JF | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and 1-palmitoyl-2-(6-(n-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine
| Article | Year |
|---|---|
12-O-tetradecanoylphorbol-13-acetate inhibits aminophospholipid translocase activity and modifies the lateral motions of fluorescent phospholipid analogs in the plasma membrane of bovine aortic endothelial cells.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Aorta; Carcinogens; Carrier Proteins; Cattle; Cell Membrane; Cells, Cultured; Endothelium, Vascular; Fibroblast Growth Factor 2; Fluorescent Dyes; Lipid Bilayers; Membrane Proteins; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylserines; Phospholipid Transfer Proteins; Phospholipids; Tetradecanoylphorbol Acetate | 1997 |